Jivadco

trastuzumab duocarmazine · medac Gesellschaft für klinische Spezialpräparate mbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Jivadco, covering 2023-11-23 to 2023-11-23. Get the full timeline:

Most recent: EMA Application withdrawn: Jivadco (trastuzumab duocarmazine) — medac Gesellschaft für klinische Spezialpräparate mbH